Veer Health Care Eyes Global Expansion and Revenue Surge
Veer Health Care aims to double its revenue to Rs 40 crore this fiscal year, driven by international market expansion. The company, known for its Ayuveer brand, is increasing exports to the U.S. and pursuing the Russian market. It also plans to diversify into the US medical devices market.

- Country:
- India
Veer Health Care has announced an ambitious plan to more than double its revenue, targeting Rs 40 crore for the current fiscal year. This growth is projected to come largely from expanding its presence in international markets, according to a company statement released on Thursday.
The company, renowned for its Ayuveer brand of ayurvedic and natural personal care products, is focusing on scaling up exports and enhancing operational efficiency at its fully-capacity manufacturing facility in Vapi. It reported a significant revenue uptick of 22.38% year-on-year for FY 2024-2025, reaching Rs 17.88 crore.
Veer Health Care's compliance approval from the USFDA has opened new opportunities in the U.S. market, where it plans to increase its monthly shipments substantially. Additionally, the company is negotiating with a Russian corporate group to tap into new markets, while also venturing into the US medical devices sector.
(With inputs from agencies.)
ALSO READ
India Eyes Competitive Edge in US Markets Amidst Tariff Wars
Tariff Tensions: US Markets React to Trump's Latest Threats
India's Chemical Export Opportunity: A US Market Shift
Lupin Launches Generic Eye Medication in US Market
WhatsApp Faces Potential Exit from Russian Market Amid National Security Concerns